TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ZBIO

Zenas BioPharma, Inc.

Healthcare · Biotechnology

27.00$ +0.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ZBIO
Line item 2022 2023 2024 2025
– – – –
– +44.9% +21.2% -1,468.6%
– +374.2% +209.6% +143.5%
– -200.9% – -96.3%
– -99.2% +670.6% -86.3%
– -99.2% +179,617.6% +724.5%
– – – –
– – -100.0% –
– -66.1% +1,952.9% -47.9%
– – – -179.6%
– – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?